Omega-3 fatty acids may be relevant for women experiencing postpartum depression, according to a small randomized pilot study published in Acta Psychiatrica Scandinavica (2006;113(1):31–35). The study, titled “Randomized dose-ranging pilot trial of omega-3 fatty acids for postpartum depression,” evaluated the effects of varying doses of omega-3 fatty acids in newly postpartum women.
The study included 16 women with postpartum depression, who were randomly assigned to one of three dosage groups. Participants received either 0.5 grams, 1.4 grams, or 2.8 grams of omega-3 fatty acids daily for eight weeks. Depressive symptoms were assessed using the Edinburgh Postnatal Depression Scale (EPDS) and the Hamilton Rating Scale for Depression (HRSD).
At baseline, the mean EPDS score was 18.1 and the mean HRSD score was 19.1, indicating moderate depressive symptoms. After eight weeks of supplementation, the mean EPDS score declined to 9.3—representing a 51.3% improvement—while the mean HRSD score fell to 10.0, a 48.8% improvement.
Although limited by its small sample size and lack of a placebo control, the study demonstrated meaningful reductions in depressive symptom scores across dosage groups. The authors concluded that omega-3 fatty acids showed promising potential for postpartum depression and emphasized the need for larger, well-controlled trials to confirm these findings.
